AMY2B
gene geneOn this page
Summary
AMY2B (amylase alpha 2B, HGNC:478) is a protein-coding gene on chromosome 1p21.1, encoding Alpha-amylase 2B (P19961).
Amylases are secreted proteins that hydrolyze 1,4-alpha-glucoside bonds in oligosaccharides and polysaccharides, and thus catalyze the first step in digestion of dietary starch and glycogen. The human genome has a cluster of several amylase genes that are expressed at high levels in either salivary gland or pancreas. This gene encodes an amylase isoenzyme produced by the pancreas.
Source: NCBI Gene 280 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 124 total
- MANE Select transcript:
NM_001387437
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:478 |
| Approved symbol | AMY2B |
| Name | amylase alpha 2B |
| Location | 1p21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000240038 |
| Ensembl biotype | protein_coding |
| OMIM | 104660 |
| Entrez | 280 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 4 protein_coding, 3 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000361355, ENST00000435302, ENST00000453959, ENST00000462971, ENST00000477657, ENST00000481821, ENST00000491397, ENST00000684275
RefSeq mRNA: 3 — MANE Select: NM_001387437
NM_001386109, NM_001387437, NM_020978
CCDS: CCDS782
Canonical transcript exons
ENST00000684275 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001642465 | 103579311 | 103579534 |
| ENSE00001712096 | 103577490 | 103577608 |
| ENSE00001757213 | 103571589 | 103571770 |
| ENSE00003491719 | 103577720 | 103577845 |
| ENSE00003492811 | 103575441 | 103575540 |
| ENSE00003566157 | 103574260 | 103574393 |
| ENSE00003569561 | 103573708 | 103573938 |
| ENSE00003586191 | 103572110 | 103572256 |
| ENSE00003587145 | 103573063 | 103573260 |
| ENSE00003612859 | 103575223 | 103575345 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 99.81.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3482 / max 343.4818, expressed in 54 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 4300 | 0.1904 | 51 |
| 4301 | 0.1123 | 4 |
| 4299 | 0.0455 | 6 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of pancreas | UBERON:0001150 | 99.81 | gold quality |
| right uterine tube | UBERON:0001302 | 98.46 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 97.06 | gold quality |
| cerebellar cortex | UBERON:0002129 | 97.02 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 97.02 | gold quality |
| cerebellum | UBERON:0002037 | 96.79 | gold quality |
| mucosa of stomach | UBERON:0001199 | 96.29 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 96.04 | gold quality |
| tibial nerve | UBERON:0001323 | 95.98 | gold quality |
| thyroid gland | UBERON:0002046 | 95.93 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 95.83 | gold quality |
| apex of heart | UBERON:0002098 | 95.76 | gold quality |
| calcaneal tendon | UBERON:0003701 | 95.54 | gold quality |
| nucleus accumbens | UBERON:0001882 | 95.40 | gold quality |
| gastrocnemius | UBERON:0001388 | 95.15 | gold quality |
| muscle of leg | UBERON:0001383 | 95.07 | gold quality |
| pancreas | UBERON:0001264 | 95.01 | gold quality |
| caudate nucleus | UBERON:0001873 | 94.77 | gold quality |
| putamen | UBERON:0001874 | 94.59 | gold quality |
| cortex of kidney | UBERON:0001225 | 94.53 | gold quality |
| right frontal lobe | UBERON:0002810 | 94.53 | gold quality |
| metanephros cortex | UBERON:0010533 | 94.30 | gold quality |
| right atrium auricular region | UBERON:0006631 | 94.12 | gold quality |
| pituitary gland | UBERON:0000007 | 94.11 | gold quality |
| left ovary | UBERON:0002119 | 94.03 | gold quality |
| right lung | UBERON:0002167 | 94.03 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 94.03 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 94.03 | gold quality |
| endocervix | UBERON:0000458 | 93.97 | gold quality |
| left uterine tube | UBERON:0001303 | 93.91 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-119 | yes | 39.86 |
| E-GEOD-81547 | yes | 23.44 |
| E-GEOD-100618 | no | 310.75 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 3)
- It was concluded that the genetic variant determining starch metabolism influences the response to weight-loss dietary intervention. Overweight and obese individuals carrying the AMY1-AMY2 rs11185098 genotype associated with higher amylase activity may have greater loss of adiposity during low-calorie diet interventions. (PMID:28659346)
- A significant link between serum amylase activity and ABO blood type in Chinese subjects. (PMID:30938472)
- alpha-Amylase expressed in human small intestinal epithelial cells is essential for cell proliferation and differentiation. (PMID:31478242)
Cross-species orthologs
12 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| drosophila_melanogaster | Amy-d | FBGN0000078 |
| drosophila_melanogaster | Amy-p | FBGN0000079 |
| drosophila_melanogaster | Mal-A2 | FBGN0002569 |
| drosophila_melanogaster | Mal-A3 | FBGN0002571 |
| drosophila_melanogaster | Amyrel | FBGN0020506 |
| drosophila_melanogaster | Mal-B1 | FBGN0032381 |
| drosophila_melanogaster | Mal-B2 | FBGN0032382 |
| drosophila_melanogaster | Mal-A4 | FBGN0033294 |
| drosophila_melanogaster | Mal-A7 | FBGN0033296 |
| drosophila_melanogaster | Mal-A8 | FBGN0033297 |
| drosophila_melanogaster | Mal-A6 | FBGN0050360 |
| caenorhabditis_elegans | WBGENE00008220 |
Paralogs (7): GBE1 (ENSG00000114480), SLC3A1 (ENSG00000138079), SLC3A2 (ENSG00000168003), AMY1B (ENSG00000174876), AMY1C (ENSG00000187733), AMY1A (ENSG00000237763), AMY2A (ENSG00000243480)
Protein
Protein identifiers
Alpha-amylase 2B — P19961 (reviewed: P19961)
Alternative names: 1,4-alpha-D-glucan glucanohydrolase 2B, Carcinoid alpha-amylase
All UniProt accessions (3): P19961, C9J2Z5, C9JWK7
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Monomer.
Subcellular location. Secreted.
Cofactor. Binds 1 Ca(2+) ion per subunit. Binds 1 Cl(-) ion per subunit.
Similarity. Belongs to the glycosyl hydrolase 13 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P19961-1 | 1 | yes |
| P19961-2 | 2 |
RefSeq proteins (3): NP_001373038, NP_001374366, NP_066188 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR006046 | Alpha_amylase | Family |
| IPR006047 | GH13_cat_dom | Domain |
| IPR006048 | A-amylase/branching_C | Domain |
| IPR013780 | Glyco_hydro_b | Homologous_superfamily |
| IPR017853 | GH_hydrolase_sf | Homologous_superfamily |
| IPR031319 | A-amylase_C | Domain |
Pfam: PF00128, PF02806
UniProt features (20 total): binding site 7, disulfide bond 5, splice variant 2, active site 2, signal peptide 1, chain 1, site 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P19961-F1 | 96.70 | 0.96 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (3): 315 (transition state stabilizer); 212 (nucleophile); 248 (proton donor)
Ligand- & substrate-binding residues (7): 352; 115; 173; 182; 210; 216; 313
Post-translational modifications (1): 16
Disulfide bonds (5): 43–101, 85–130, 156–175, 393–399, 465–477
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-189085 | Digestion of dietary carbohydrate |
| R-HSA-8935690 | Digestion |
| R-HSA-8963743 | Digestion and absorption |
MSigDB gene sets: 55 (showing top):
MODULE_92, WANG_CLIM2_TARGETS_UP, MODULE_255, REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE, MODULE_317, NKX61_01, FREAC3_01, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4, SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP, GOBP_CARBOHYDRATE_METABOLIC_PROCESS, TGANTCA_AP1_C, KEGG_STARCH_AND_SUCROSE_METABOLISM, MODULE_88, AACTTT_UNKNOWN, CUI_TCF21_TARGETS_2_DN
GO Biological Process (1): carbohydrate metabolic process (GO:0005975)
GO Molecular Function (8): alpha-amylase activity (GO:0004556), calcium ion binding (GO:0005509), chloride ion binding (GO:0031404), catalytic activity (GO:0003824), hydrolase activity (GO:0016787), hydrolase activity, acting on glycosyl bonds (GO:0016798), cation binding (GO:0043169), metal ion binding (GO:0046872)
GO Cellular Component (3): obsolete extracellular space (GO:0005615), extracellular exosome (GO:0070062), extracellular region (GO:0005576)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Digestion | 1 |
| Digestion and absorption | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| primary metabolic process | 1 |
| amylase activity | 1 |
| metal ion binding | 1 |
| anion binding | 1 |
| molecular_function | 1 |
| catalytic activity | 1 |
| hydrolase activity | 1 |
| ion binding | 1 |
| cation binding | 1 |
| extracellular vesicle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1728 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| AMY2B | MGAM | O43451 | 986 |
| AMY2B | MGAM2 | Q2M2H8 | 986 |
| AMY2B | SI | P14410 | 924 |
| AMY2B | GYG1 | P46976 | 838 |
| AMY2B | CTRB1 | P17538 | 835 |
| AMY2B | CTRB2 | Q6GPI1 | 834 |
| AMY2B | GYG2 | O15488 | 828 |
| AMY2B | HAO1 | Q9UJM8 | 825 |
| AMY2B | ALB | P02768 | 737 |
| AMY2B | PNLIP | P16233 | 729 |
| AMY2B | INS | P01308 | 692 |
| AMY2B | MANBA | O00462 | 686 |
| AMY2B | BCHE | P06276 | 676 |
| AMY2B | BPI | P17213 | 666 |
| AMY2B | ATP1A1 | P05023 | 653 |
IntAct
13 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DUSP4 | MYO1C | psi-mi:“MI:0914”(association) | 0.350 |
| DUSP4 | PSMD11 | psi-mi:“MI:0914”(association) | 0.350 |
| P | psi-mi:“MI:0914”(association) | 0.350 | |
| ORF10 | HSPA5 | psi-mi:“MI:0914”(association) | 0.350 |
| ZBTB18 | CBR3 | psi-mi:“MI:0914”(association) | 0.350 |
| AMY2A | GYG2 | psi-mi:“MI:0914”(association) | 0.350 |
| AMY1A | GYG2 | psi-mi:“MI:0914”(association) | 0.350 |
| AMY2A | GYS1 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF843 | AMY2A | psi-mi:“MI:0914”(association) | 0.350 |
| AMY2B | FOS | psi-mi:“MI:0915”(physical association) | 0.000 |
| tkt1 | AMY2B | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (9): AMY2B (Affinity Capture-MS), AMY2B (Affinity Capture-RNA), AMY2B (Affinity Capture-MS), AMY2B (Affinity Capture-MS), AMY2B (Affinity Capture-MS), AMY2B (Affinity Capture-MS), AMY2B (Affinity Capture-MS), AMY2B (Affinity Capture-MS), AMY2B (Affinity Capture-MS)
ESM2 similar proteins: H2N0D4, O18344, O18345, O18408, O18420, O18552, O76260, O76261, O76262, O76263, O76264, O76265, O76284, O76459, O77011, O77012, O77013, O77014, O77015, O77016, O77018, O77019, O77020, O77021, O77022, O97396, P00687, P00688, P00689, P00690, P04063, P04746, P04750, P08144, P09107, P0DTE7, P0DTE8, P0DUB6, P19961, P54215
Diamond homologs: A0A096XJN4, B0KZK1, H2N0D4, O18344, O18345, O18408, O18420, O18552, O76260, O76261, O76262, O76263, O76264, O76265, O76284, O76459, O77011, O77012, O77013, O77014, O77015, O77016, O77018, O77019, O77020, O77021, O77022, O97396, P00687, P00688, P00689, P00690, P04746, P08144, P08486, P09107, P09794, P0DTE7, P0DTE8, P0DUB6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
124 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 98 |
| Likely benign | 10 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1840 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:103565899:T:TA | acceptor_gain | 1.0000 |
| 1:103573062:GGTTC:G | acceptor_gain | 1.0000 |
| 1:103573257:TCAG:T | donor_loss | 1.0000 |
| 1:103573258:CAG:C | donor_loss | 1.0000 |
| 1:103573259:AGGTA:A | donor_loss | 1.0000 |
| 1:103573260:GGTAA:G | donor_loss | 1.0000 |
| 1:103573261:GTAA:G | donor_loss | 1.0000 |
| 1:103573895:G:GG | donor_gain | 1.0000 |
| 1:103573912:GGAA:G | donor_gain | 1.0000 |
| 1:103573913:G:GT | donor_gain | 1.0000 |
| 1:103573913:G:T | donor_gain | 1.0000 |
| 1:103573936:G:GT | donor_gain | 1.0000 |
| 1:103574256:CTAGG:C | acceptor_loss | 1.0000 |
| 1:103574257:TAG:T | acceptor_loss | 1.0000 |
| 1:103574258:A:T | acceptor_loss | 1.0000 |
| 1:103574259:G:GT | acceptor_loss | 1.0000 |
| 1:103574392:AAGT:A | donor_loss | 1.0000 |
| 1:103574393:AGT:A | donor_loss | 1.0000 |
| 1:103574394:G:GG | donor_gain | 1.0000 |
| 1:103575338:GATGC:G | donor_gain | 1.0000 |
| 1:103575342:C:G | donor_gain | 1.0000 |
| 1:103575439:A:AG | acceptor_gain | 1.0000 |
| 1:103575440:G:GG | acceptor_gain | 1.0000 |
| 1:103575440:GGCT:G | acceptor_gain | 1.0000 |
| 1:103577483:A:AG | acceptor_gain | 1.0000 |
| 1:103577717:TA:T | acceptor_loss | 1.0000 |
| 1:103577718:A:AG | acceptor_gain | 1.0000 |
| 1:103577718:AG:A | acceptor_gain | 1.0000 |
| 1:103577718:AGGAA:A | acceptor_loss | 1.0000 |
| 1:103577719:G:GG | acceptor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000077186 (1:103575013 GGTGT>G,GGT,GGTGTGT), RS1000260855 (1:103569589 G>C), RS1000381755 (1:103557418 A>G,T), RS1000515817 (1:103564242 A>C), RS1000549551 (1:103574810 T>C), RS1000589493 (1:103563958 A>G), RS1000653370 (1:103565508 A>G), RS1000837823 (1:103563614 C>G,T), RS1001017611 (1:103574066 C>G,T), RS1001151037 (1:103569675 G>A,C), RS1001227350 (1:103568732 T>A), RS1001246377 (1:103561216 G>A), RS1001341358 (1:103556525 G>A), RS1001395237 (1:103556266 A>G), RS1001435343 (1:103569828 G>A)
Disease associations
OMIM: gene MIM:104660 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006585_2389 | Blood protein levels | 3.000000e-36 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression | 3 |
| Tetrachlorodibenzodioxin | decreases expression | 2 |
| Cyclosporine | decreases expression, increases methylation | 2 |
| Aflatoxin B1 | decreases expression, decreases methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | affects expression | 1 |
| jinfukang | decreases expression | 1 |
| Resveratrol | increases expression, affects cotreatment | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Cisplatin | increases expression | 1 |
| Estradiol | increases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.